Aerie Pharmaceuticals, Inc. Operating Lease, Expense
Aerie Pharmaceuticals, Inc. reported Operating Lease, Expense of $5.90 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-02-25
- Aerie Pharmaceuticals, Inc. operating lease, expense for fiscal 2021 was $5.90M, a 5.36% increase from fiscal 2020.
- Aerie Pharmaceuticals, Inc. operating lease, expense for fiscal 2020 was $5.60M, a 5.66% increase from fiscal 2019.
- Aerie Pharmaceuticals, Inc. operating lease, expense for fiscal 2019 was $5.30M.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2021-12-31 | $5.90M 10-K · filed 2022-02-25 |
| 2020-12-31 | $5.60M 10-K · filed 2022-02-25 |
| 2019-12-31 | $5.30M 10-K · filed 2021-02-26 |